Healthcare Global Enterprises Limited — Board Meeting, 12-11-2025: Outcome of Board Meeting
12-11-2025 | 05:54 pm
12-11-2025 | 05:54 pm
HCG's board approved the financial results for the quarter and half-year ended Sept 30, 2025. Consolidated profit for the quarter stood at ₹20.66 Cr and for the half-year at ₹34.31 Cr. The company will also invest up to ₹7 Cr in Cancer Care Kenya, a step-down subsidiary.
No comments yet. Be the first to comment!
All announcements from Healthcare Global Enterprises Limited
